Subscribe

Drägerwerk AG & Co. KGaA (DRW3.DE)

EUR85.10 +1.70 (+2.04%)
DE XETRA Healthcare Medical - Devices
Address Moislinger Allee 53-55 23558
Lübeck, DE
CEO Stefan A. Drager
Website draeger.com
IPO 1998-11-12
ISIN DE0005550636

Explore sections of this company profile

Also trades on Deutsche Börse · DRW3.DE (EUR) Deutsche Börse · DRW8.DE (EUR) London Stock Exchange · 0MT8.L (EUR) Other OTC · DGWPF (USD) Other OTC · DRWKF (USD) Other OTC · DWRKF (USD)
Description

Headquartered in Lübeck, Germany, and established in 1889, Drägerwerk AG & Co. KGaA is an international enterprise specializing in medical and safety technology, with operations spanning Europe, the Americas, Africa, Asia, and Australia. For the healthcare sector, the company engineers, produces, and commercializes comprehensive solutions, apparatus, and related services tailored for acute care environments, such as emergency, perioperative, critical, and perinatal settings. Key offerings in this domain include anesthesia equipment, respiratory ventilators, thermoregulation devices, patient monitoring systems, supply units, lighting, gas management solutions, software applications, and various consumables and accessories. In the realm of safety, Drägerwerk delivers products, integrated systems, and support for personal protection, gas detection, and holistic hazard management. These provisions serve diverse clients across industrial and mining sectors, as well as public services like fire departments, law enforcement, and disaster preparedness agencies. The safety product range features both stationary and mobile gas detection systems, personal protective gear, and devices for alcohol and drug screening. Furthermore, Drägerwerk extends its expertise through various training programs and services, alongside dedicated fire training facilities for emergency responders.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
EUR85.10 +1.70 (+2.04%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
15.9K
Beta
0.59
Float Shares
18.39M
Free Float %
98.0%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-3.06% -5.63% -9.52% -1.27% +25.00% +25.00% +40.86% +80.76% +16.25% +38.73% +514.67%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
85.10
DCF (Unlevered) 320.12 +276.2%
DCF (Levered) 98.38 +15.6%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 60% Bullish
Rating 2026-05 Change
Strong Buy 1 0
Buy 2 -1
Hold 2 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
2.98
Grey zone
Piotroski F-Score
7 / 9
Strong
MOAT Score
6 / 10
Developing
Composite Rating
A
Overall Score
4 / 5
High
DCF Score
4 / 5
High
ROE Score
4 / 5
High
ROA Score
4 / 5
High
D/E Score
3 / 5
Medium
P/E Score
3 / 5
Medium
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
  • ✗
    Revenue growth Medical - Devices: +11.2%
    +3.3% Q1'26: +3.5% (vs Q1'25)
  • ✓
    EPS growth Medical - Devices: +28.5%
    +12.6% Q1'26: +608.3% (vs Q1'25)
  • ✓
    FCF margin FCF growth · Medical - Devices: +30.9%
    +4.5% ★ Q1'26: +5.0% (vs Q1'25)
  • ✗
    EBIT margin Medical - Devices: +6.2%
    +6.8% ★ Q1'26: +2.6% (vs Q1'25)
  • ✗
    ROIC Medical - Devices: +3.3%
    +8.9% ★ Q1'26: +3.5% (vs Q1'25)
  • ✓
    Share dilution Medical - Devices: 0.0%
    -0.1% ★ Q1'26: +7.9% (vs Q1'25)
  • ✓
    Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×
    1.05× Q1'26: 1.10× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.56) × ERP
WACC = 80% × Ke + 20% × Kd (5.7%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Intrinsic value (base): 316.84 Current price: 85.10
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2015
actual 		Dec 2016
actual 		Dec 2017
actual 		Dec 2018
actual 		Dec 2019
actual 		Dec 2020
actual 		Dec 2021
actual 		Dec 2022
actual 		Dec 2023
actual 		Dec 2024
actual 		Dec 2025
actual 		Dec 2026
5 Rev. Ana.
2 EPS Ana. 		Dec 2027
5 Rev. Ana.
4 EPS Ana. 		Dec 2028
3 Rev. Ana.
2 EPS Ana. 		Dec 2029
2 Rev. Ana.
1 EPS Ana.
Revenue
2.61B
est: 2.59B (+0.8%)
2.52B
est: 2.53B (-0.4%)
2.57B
est: 2.57B (+0.1%)
2.60B
est: 2.60B (-0.2%)
2.78B
est: 2.76B (+0.6%)
3.41B
est: 3.39B (+0.6%)
3.33B
est: 3.30B (+0.9%)
3.05B
est: 3.00B (+1.5%)
3.37B
est: 3.36B (+0.4%)
3.37B
est: 3.38B (-0.3%)
3.48B
est: 3.48B (+0.1%)
3.62B
3.56B – 3.67B
+4.0% YoY
3.77B
3.67B – 3.87B
+4.3% YoY
3.96B
3.95B – 3.96B
+4.9% YoY
3.92B
3.84B – 4.00B
-1.0% YoY
EBITDA
79.50M
est: 232.49M (-65.8%)
140.65M
est: 227.59M (-38.2%)
159.37M
est: 230.90M (-31.0%)
66.61M
est: 233.57M (-71.5%)
197.42M
est: 248.31M (-20.5%)
399.92M
est: 304.28M (+31.4%)
374.43M
est: 296.32M (+26.4%)
62.63M
est: 269.55M (-76.8%)
318.33M
est: 495.90M (-35.8%)
351.68M
est: 498.66M (-29.5%)
384.83M
est: 513.11M (-25.0%)
533.42M
525.13M – 542.10M
+4.0% YoY
556.36M
542.02M – 570.44M
+4.3% YoY
583.73M
583.22M – 584.25M
+4.9% YoY
578.13M
566.12M – 590.20M
-1.0% YoY
EBIT
70.67M
est: 146.87M (-51.9%)
140.65M
est: 143.78M (-2.2%)
159.37M
est: 145.87M (+9.3%)
66.61M
est: 147.56M (-54.9%)
70.16M
est: 156.86M (-55.3%)
399.92M
est: 192.22M (+108.1%)
272.34M
est: 187.20M (+45.5%)
-81.83M
est: 170.29M (-148.1%)
169.78M
est: 323.46M (-47.5%)
205.83M
est: 325.26M (-36.7%)
238.28M
est: 334.68M (-28.8%)
347.93M
342.52M – 353.59M
+4.0% YoY
362.89M
353.54M – 372.07M
+4.3% YoY
380.75M
380.41M – 381.08M
+4.9% YoY
377.09M
369.26M – 384.96M
-1.0% YoY
Net Income
33.58M
est: 32.63M (+2.9%)
82.08M
est: 75.38M (+8.9%)
98.47M
est: 91.61M (+7.5%)
34.36M
est: 23.17M (+48.3%)
33.35M
est: 37.09M (-10.1%)
188.59M
est: 205.35M (-8.2%)
154.23M
est: 157.37M (-2.0%)
-64.56M
est: -87.28M (+26.0%)
110.43M
est: 116.40M (-5.1%)
124.41M
est: 112.76M (+10.3%)
139.50M
est: 131.30M (+6.2%)
147.94M
133.60M – 160.79M
+12.7% YoY
150.88M
128.17M – 200.37M
+2.0% YoY
198.68M
182.30M – 215.07M
+31.7% YoY
204.43M
198.91M – 209.98M
+2.9% YoY
SGA
861.18M
est: 750.45M (+14.8%)
762.10M
est: 734.64M (+3.7%)
764.00M
est: 745.32M (+2.5%)
791.09M
est: 753.95M (+4.9%)
841.35M
est: 801.51M (+5.0%)
907.09M
est: 982.18M (-7.6%)
934.04M
est: 956.49M (-2.3%)
976.54M
est: 870.09M (+12.2%)
955.68M
est: 979.87M (-2.5%)
1.01B
est: 985.32M (+2.3%)
953.66M
est: 1.01B (-5.9%)
1.05B
1.04B – 1.07B
+4.0% YoY
1.10B
1.07B – 1.13B
+4.3% YoY
1.15B
1.15B – 1.15B
+4.9% YoY
1.14B
1.12B – 1.17B
-1.0% YoY
EPS
1.40
est: 1.74 (-19.5%)
3.40
est: 4.02 (-15.4%)
4.12
est: 4.88 (-15.6%)
1.42
est: 1.24 (+15.0%)
1.40
est: 1.98 (-29.2%)
10.22
est: 10.95 (-6.6%)
7.16
est: 8.39 (-14.6%)
-3.44
est: -4.65 (+26.1%)
5.86
est: 6.20 (-5.6%)
6.61
est: 6.02 (+9.9%)
7.44
est: 6.95 (+7.0%)
7.75
7.13 – 8.58
+11.4% YoY
8.70
6.84 – 10.69
+12.3% YoY
10.60
9.73 – 11.48
+21.8% YoY
10.91
10.62 – 11.21
+2.9% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-11 A 4/5 4/5 4/5 4/5 3/5 3/5 4/5
2026-05-08 A 4/5 4/5 4/5 4/5 3/5 3/5 4/5
2026-05-07 A 4/5 4/5 4/5 4/5 3/5 3/5 4/5
2026-05-06 A 4/5 4/5 4/5 4/5 3/5 3/5 4/5
2026-05-05 A- 4/5 4/5 3/5 4/5 2/5 4/5 4/5
2026-05-04 A- 4/5 4/5 3/5 4/5 2/5 4/5 4/5
2026-04-30 A- 4/5 4/5 3/5 4/5 2/5 4/5 4/5
2026-04-29 A- 4/5 4/5 3/5 4/5 2/5 4/5 4/5
2026-04-28 A- 4/5 4/5 3/5 4/5 2/5 4/5 4/5
2026-04-27 A- 4/5 4/5 3/5 4/5 2/5 4/5 4/5
2026-04-24 A- 4/5 4/5 3/5 5/5 2/5 3/5 4/5
2026-04-23 A- 4/5 4/5 3/5 5/5 1/5 3/5 4/5
2026-04-22 A- 4/5 4/5 3/5 5/5 1/5 3/5 4/5
2026-04-21 A- 4/5 4/5 3/5 5/5 1/5 3/5 4/5
2026-04-20 A- 4/5 4/5 3/5 5/5 1/5 3/5 4/5
2026-04-17 A- 4/5 4/5 3/5 5/5 1/5 3/5 4/5
2026-04-16 A- 4/5 4/5 3/5 5/5 1/5 3/5 4/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
184.98M
OE per share TTM
9.88
Owner's Yield
11.18%
Maintenance CapEx ratio
171.67%
Maint CapEx / Avg PPE
17.4%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock Held by 60 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 Amundi SDAX UCITS ETF Dist C005.DE 1.73% 3.09M 0.70%
2 iShares TecDAX UCITS ETF (DE) EXS2.DE 0.58% 4.07M 0.51%
3 iShares TecDAX UCITS ETF (DE) EXIB.DE 0.58% 74.9K 0.51%
4 Amundi TecDAX UCITS ETF Dist E908.DE 0.56% 527.1K 0.40%
5 UBS MSCI EMU Small Cap UCITS ETF EUR dis UEFD.DE 0.13% 986.4K 0.33%
6 iShares MSCI EMU Small Cap UCITS ETF CES1.L 0.13% 1.37M 0.58%
7 iShares International Developed Small Cap Value Factor ETF ISVL 0.12% 368.6K 0.31%
8 iShares International Small-Cap Equity Factor ETF ISCF 0.11% 702.1K 0.24%
9 State Street SPDR MSCI Europe Small Cap Value Weighted UCITS ETF EUR Acc ZPRX.DE 0.09% 707.8K 0.30%
10 Dimensional - International Small Cap Value ETF DISV 0.06% 3.08M 0.42%

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
15.4K
Shares Outstanding
18.76M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Stefan A. Drager Chairman of the Executive Board - Drägerwerk Verwaltungs AG 1M male
Rainer Klug Executive Board Member for Safety Division - Drägerwerk Verwaltungs AG 932.7K male
Gert-Hartwig Lescow Chief Financial Officer, Executive Board Member for IT & Vice Chairman of Executive Board - Drägerwerk Verwaltungs AG 931.9K male
Reiner Piske Executive Board Member for Sales & Human Resources - Drägerwerk Verwaltungs AG 700.4K —
Anton Schrofner Executive Board Member for Medical Division - Drägerwerk Verwaltungs AG 630.8K male
Stefanie Hirsch Executive Board Member for Sustainability & Quality - Drägerwerk Verwaltungs AG 344.7K female
Thomas Fischler Head of Treasury & Investor Relations — male
Welf Böttcher Head of Corporation Communications — male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Medical - Devices